Skip to main content

Vanderbilt Ingram Cancer Center

Mouth health and colorectal cancer

Jun. 6, 2019—Microbial species in the mouth could be playing a role in colorectal cancer development, according to new research from epidemiologists at VUMC.

Read more


My Southern Health: Understanding a new approach to cancer treatment

May. 31, 2019—Breast cancer expert Ben Ho Park, M.D., is the new director of Precision Oncology at Vanderbilt-Ingram Cancer Center. Dr. Park explains his groundbreaking research on the genetic events that lead to cancer, and what that means for the future of cancer treatment.

Read more


Technology better than tape measure for identifying lymphedema risk

May. 6, 2019—New research by School of Nursing professor Sheila Ridner finds that a special scan measuring lymphatic fluid volume is significantly better than a tape measure at predicting which women undergoing treatment for breast cancer are at risk of developing a common complication resulting from damaged lymph nodes.

Read more


Asian nations in early tobacco epidemic: study

Apr. 18, 2019—Asian countries are in the early stages of a tobacco smoking epidemic with habits mirroring those of the United States from past decades, setting the stage for a spike in future deaths from smoking-related diseases.

Read more


Study shows magnesium optimizes vitamin D status

Dec. 19, 2018—A randomized trial by Vanderbilt-Ingram Cancer Center researchers indicates that magnesium optimizes vitamin D status, raising it in people with deficient levels and lowering it in people with high levels.

Read more


Lung cancer survival signal

Nov. 30, 2018—New research by Jonathan Lehman and Pierre Massion have identfied a bioimarker that suggests poor prognosis for small-cell lung cancer, as well as potential target for new therapies.

Read more


Grant enhances study of new chemotherapy targets

Oct. 19, 2018—Vanderbilt chemists have been awarded $7.2 million over the next five years from the National Cancer Institute to lead an initiative to better understand how a combination chemotherapy for breast cancer targets DNA.

Read more


Study tracks incidence, timing of immunotherapy-related deaths

Sep. 13, 2018—Researchers led by melanoma researcher Douglas Johnson have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Read more


My Southern Health: The symptoms of cholangiocarcinoma

Jul. 13, 2018—The signs of this rare bile-duct cancer typically go unnoticed at first. Here’s what to know.

Read more


Lung cancer patients and advocates visit VUMC research labs

Jun. 14, 2018—A group of young lung cancer patients and their family members recently toured research laboratories at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center (VICC) to learn how investigators are working to find better therapies and possibly a cure for the disease.

Read more


Jagasia to succeed Neuss as VICC Chief Medical Officer

Jun. 12, 2018—After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverley Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic.

Read more


VUMC and VICC lauded by CEO Roundtable on Cancer for employee support

May. 31, 2018—For the 10th year in a row Vanderbilt University Medical Center (VUMC) and Vanderbilt-Ingram Cancer Center (VICC) have been named a CEO Cancer Gold Standard employer by the

Read more


Upcoming Events

MORE EVENTS »